A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses
Burgueño, Javier (Laboratoris Esteve. Department of Pharmacology, Drug Discovery & Preclinical Development)
Pujol Argemí, Marta (Laboratoris Esteve. Department of Pharmacology, Drug Discovery & Preclinical Development)
Monroy, Xavier (Laboratoris Esteve. Department of Pharmacology, Drug Discovery & Preclinical Development)
Roche, David (Universitat Internacional de Catalunya. Facultat de Ciències Econòmiques i Socials)
Varela, Maria Jose (Universidade de Santiago de Compostela)
Merlos, Manuel (Laboratoris Esteve. Department of Pharmacology, Drug Discovery & Preclinical Development)
Giraldo, Jesús
(Universitat Autònoma de Barcelona. Institut de Neurociències)
Universitat Autònoma de Barcelona.
Departament de Pediatria, Obstetrícia i Ginecologia i de Medicina Preventiva i Salut Pública
| Date: |
2017 |
| Abstract: |
Compelling data in the literature from the recent years leave no doubt about the pluridimensional nature of G protein-coupled receptor function and the fact that some ligands can couple with different efficacies to the multiple pathways that a receptor can signal through, a phenomenon most commonly known as functional selectivity or biased agonism. Nowadays, transduction coefficients (log(τ/K)), based on the Black and Leff operational model of agonism, are widely used to calculate bias. Nevertheless, combining both affinity and efficacy in a single parameter can result in compounds showing a defined calculated bias of one pathway over other though displaying varying experimental bias preferences. In this paper, we present a novel scale (log(τ)), that attempts to give extra substance to different compound profiles in order to better classify compounds and quantify their bias. The efficacy-driven log(τ) scale is not proposed as an alternative to the affinity&efficacy-driven log(τ/K) scale but as a complement in those situations where partial agonism is present. Both theoretical and practical approaches using μ-opioid receptor agonists are presented. |
| Grants: |
Ministerio de Economía y Competitividad 2013-018-C03-02 Ministerio de Economía y Competitividad SAF2014-58396-R
|
| Rights: |
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.  |
| Language: |
Anglès |
| Document: |
Article ; recerca ; Versió publicada |
| Published in: |
Scientific reports, Vol. 7 (november 2017) , ISSN 2045-2322 |
DOI: 10.1038/s41598-017-15258-z
PMID: 29133887
The record appears in these collections:
Research literature >
UAB research groups literature >
Research Centres and Groups (research output) >
Health sciences and biosciences >
Institut de Neurociències (INc)Articles >
Research articlesArticles >
Published articles
Record created 2022-02-07, last modified 2024-11-20